Co-founder & CEO
D.U microsurgery, multi-species experience
Author of a doctoral thesis dedicated to the use of mAbs against infectious agents.
Co-founder & General Manager
Past President & Founder of CRO Clinica & Statistica and past CEO of WHITE-TILLET (regulatory expertise & consulting)
Currently, President of T.E.B., Expert in evaluation and regulation of health products
Successively director of the INSERM UMR 948 unit, Head of the biological products and vaccines department at the French Medicines Agency (ASNM), expert in bio-production at IT health technologies (INSERM). He is today founder of NF consulting.
Professor emeritus of toxicology at the Lille Faculty of Pharmacy, former member of the Marketing Authorization Commission of the French Medicines Agency, former expert at the EMA and EFSA, founder of the mutagenesis laboratory at Lille Pastor institute.
Professor of veterinary immunology at Montreal veterinary university (Canada). Expert in animal immuno-infectiology. He holds editorial positions in several scientific journals (Molecular Immunology, Vaccines and Frontiers in Microbiology) and conducts research in veterinary immunology, mainly on swine species.
Professor of toxicology at the Paris-Saclay Faculty of Pharmacy, Dean of the faculty, former member of the Marketing Authorization Commission of the French Medicines Agency, specialist in immuno-toxicology.
Professor emeritus of pharmacology and pharmacokinetics at the Faculty of Pharmacy of Paris V, former director of the drug evaluation service (DEMEB) at the French Agency for Health Product Safety (AFSSAPS), former president of the working group of biological products at the EMA, president since 2019 of the commission for the evaluation of biological products at the IABS.
Dipl. ECVD, International specialist in canine atopic dermatitis, author of several books and publications about veterinary dermatology, Author of scientific blog http://dermatiteatopiquecanine.org